This blog provides the information on health and disease such as Acne Medicine, Anti-Allergy,Asthma,Beauty Care,Blood Test,Breast Cancer, Cancer News,care Insurance, Cholesterol,Detox,Diabetes,Diet ,diseases,First Aid,Food Combining,Health care,Health Insurance,Health Research, Health Tips,Heart Attack, Hepatitis,Herbal Medicine,HIV, leukimia,Medicine,Neuroscience News,Osteoporosis,Oxygen Therapy,Pain Relievers.Personal care, Pregnancy,Thermometer,Vaccination ,Vitamin,Weight Loss
Friday, March 13, 2009
Dermatone SPF 30 Skin Protectant 0.5oz Tin
Dermatone SPF 30 SkinProtectant 0.5oz Tin.This break-through product was developed to help meet the needs of those with sensitive skin and those who are concerned about skin cancer-causing UVA rays. The SPF 30 was achieved by using Z-Cote® Transparent Zinc Oxide plus existing, proven sunscreens. Experts consider Zinc Oxide to be the most effective sunscreen against cancer-causing UVA rays. For centuries, it has been used to protect and soothe the skin. Classified by the FDA as a 'Skin Protectant,' it prevents chapping, cracking, and windburn. Z-Cote® is a registered trademark of BASF. After extensive testing and trials, this product was selected to be the standard issue for the Navy Seals. Stays on the skin all day. Optimal for water sports.
Subscribe to:
Post Comments (Atom)
Popular Posts
-
In Indonesia white turmeric is called "Kunir Putih". This spice is believed to be able to treat cancer. The following is the infor...
-
Description Chart your Basal Body Temperature and predict ovulation - your most fertile time of the month for conceiving a baby - with...
-
Indications Restores the skins natural cellular collagen activity - Activates fibroblast cells which create collagen and elastin - Helps...
-
Are you looking for the health information related to healthy heart? Here is the information: By using cutting-edge visual technology to...
-
Features * Composition results for 5 body segments - trunk, left arm, right arm, left leg, right leg * Accurate segmental body compo...
No comments:
Post a Comment